論文

査読有り 国際誌
2021年6月17日

The Exon Junction Complex Core Represses Cancer-Specific Mature mRNA Re-splicing: A Potential Key Role in Terminating Splicing.

International journal of molecular sciences
  • Yuta Otani
  • ,
  • Ken-Ichi Fujita
  • ,
  • Toshiki Kameyama
  • ,
  • Akila Mayeda

22
12
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.3390/ijms22126519

Using TSG101 pre-mRNA, we previously discovered cancer-specific re-splicing of mature mRNA that generates aberrant transcripts/proteins. The fact that mRNA is aberrantly re-spliced in various cancer cells implies there must be an important mechanism to prevent deleterious re-splicing on the spliced mRNA in normal cells. We thus postulated that mRNA re-splicing is controlled by specific repressors, and we searched for repressor candidates by siRNA-based screening for mRNA re-splicing activity. We found that knock-down of EIF4A3, which is a core component of the exon junction complex (EJC), significantly promoted mRNA re-splicing. Remarkably, we could recapitulate cancer-specific mRNA re-splicing in normal cells by knock-down of any of the core EJC proteins, EIF4A3, MAGOH, or RBM8A (Y14), implicating the EJC core as the repressor of mRNA re-splicing often observed in cancer cells. We propose that the EJC core is a critical mRNA quality control factor to prevent over-splicing of mature mRNA.

リンク情報
DOI
https://doi.org/10.3390/ijms22126519
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/34204574
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234774
ID情報
  • DOI : 10.3390/ijms22126519
  • PubMed ID : 34204574
  • PubMed Central 記事ID : PMC8234774

エクスポート
BibTeX RIS